Detection rates of adenomas, advanced adenomas, and colorectal cancers among the opportunistic colonoscopy screening population: a single-center, retrospective study

Abstract Background: Colorectal cancer (CRC) screening is effective in reducing CRC incidence and mortality. The aim of this study was to retrospectively determine and compare the detection rate of adenomas, advanced adenomas (AAs) and CRCs, and the number needed to screen (NNS) of individuals in an average-risk Chinese population of different ages and genders. Methods: This was a retrospective study performed at the Institute of Health Management, Chinese People's Liberation Army General Hospital. Colonoscopy results were analyzed for 53,152 individuals finally enrolled from January 2013 to December 2019. The detection rate of adenomas, AAs, or CRCs was computed and the characteristics between men and women were compared using chi-squared test. Results: The average age was 48.8 years (standard deviation [SD], 8.5 years) for men and 50.0 years (SD, 9.0 years) for women, and the gender rate was 66.27% (35,226) vs. 33.73% (17,926). The detection rates of adenomas, AAs, serrated adenomas, and CRCs were 14.58% (7750), 3.09% (1641), 1.23% (653), and 0.59% (313), respectively. Men were statistically significantly associated with higher detection rates than women in adenomas (17.20% [6058/35,226], 95% confidence interval [CI] 16.74–17.53% vs. 9.44% [1692/17,926], 95% CI 8.94–9.79%, P < 0.001), AAs (3.72% [1309], 95% CI 3.47–3.87% vs. 1.85% [332], 95% CI 1.61–2.00%, P < 0.001), and serrated adenomas (1.56% [548], 95% CI 1.43–1.69% vs. 0.59% [105], 95% CI 0.47–0.70%, P < 0.001). The detection rate of AAs in individuals aged 45 to 49 years was 3.17% (270/8510, 95% CI 2.80–3.55%) in men and 1.69% (69/4091, 95% CI 1.12–1.86%) in women, and their NNS was 31.55 (95% CI 28.17–35.71) in men and 67.11 (95% CI 53.76–89.29) in women. The NNS for AAs in men aged 45 to 49 years was close to that in women aged 65 to 69 years (29.07 [95% CI 21.05–46.73]). Conclusions: The detection rates of adenomas, AAs, and serrated adenomas are high in the asymptomatic population undergoing a physical examination and are associated with gender and age. Our findings will provide important references for effective population-based CRC screening strategies in the future.

[1]  W. Wang,et al.  Mortality and years of life lost of colorectal cancer in China, 2005–2020: findings from the national mortality surveillance system , 2021, Chinese medical journal.

[2]  Jiong Cai,et al.  Head-to-head comparison of the test performance of self-administered qualitative vs. laboratory-based quantitative fecal immunochemical tests in detecting colorectal neoplasm , 2021, Chinese medical journal.

[3]  Wanqing Chen,et al.  Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020 , 2021, Chinese medical journal.

[4]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[5]  M. Dai,et al.  Divergent detection rates of fecal immunochemical test and questionnaire-based risk assessment for detecting proximal and distal advanced colorectal adenomas , 2021, Chinese medical journal.

[6]  A. Jemal,et al.  Colonoscopy Outcomes in Average-Risk Screening Equivalent Young Adults: Data From the New Hampshire Colonoscopy Registry. , 2020, The American journal of gastroenterology.

[7]  Y. Qiao,et al.  Determinants of Participation and Detection Rate of Colorectal Cancer From a Population-Based Screening Program in China , 2020, Frontiers in Oncology.

[8]  W. Zheng,et al.  Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults , 2019, JAMA network open.

[9]  T. Wilt,et al.  Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults: A Guidance Statement From the American College of Physicians , 2019, Annals of Internal Medicine.

[10]  Jie He,et al.  Participation and yield of a population-based colorectal cancer screening programme in China , 2018, Gut.

[11]  C. Flowers,et al.  Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society , 2018, CA: a cancer journal for clinicians.

[12]  P. Cattan,et al.  Adenoma and advanced neoplasia detection rates increase from 45 years of age , 2018, World journal of gastroenterology.

[13]  Philip S Rosenberg,et al.  Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.

[14]  E. Kuipers,et al.  Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative , 2017, United European gastroenterology journal.

[15]  Hong-Kyu Kim,et al.  Prevalence and risk factors of advanced colorectal neoplasms in asymptomatic Korean people between 40 and 49 years of age , 2017, Journal of gastroenterology and hepatology.

[16]  E. Kuipers,et al.  Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative , 2016, Endoscopy.

[17]  Ahmedin Jemal,et al.  Global patterns and trends in colorectal cancer incidence and mortality , 2016, Gut.

[18]  H. Brenner,et al.  Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. , 2015, Gastroenterology.

[19]  N. Segnan,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[20]  Christopher D. Jensen,et al.  Adenoma detection rate and risk of colorectal cancer and death. , 2014, The New England journal of medicine.

[21]  D. Ransohoff,et al.  Multitarget stool DNA testing for colorectal-cancer screening. , 2014, The New England journal of medicine.

[22]  Christopher I Amos,et al.  Serrated and Adenomatous Polyp Detection Increases With Longer Withdrawal Time: Results From the New Hampshire Colonoscopy Registry , 2014, The American Journal of Gastroenterology.

[23]  M. Goodrich,et al.  Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  K. Rajan,et al.  Advanced Adenoma Detection Rate Is Independent of Nonadvanced Adenoma Detection Rate , 2013, The American Journal of Gastroenterology.

[25]  U. Ladabaum,et al.  Comparative Effectiveness and Cost-Effectiveness of Screening Colonoscopy vs. Sigmoidoscopy and Alternative Strategies , 2013, The American Journal of Gastroenterology.

[26]  Monika Ferlitsch,et al.  Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. , 2011, JAMA.

[27]  Ren Chen,et al.  Detection of Colorectal Neoplasia by Colonoscopy in Average-Risk Patients Age 40–49 Versus 50–59 Years , 2011, Digestive Diseases and Sciences.

[28]  G. Austin,et al.  Level of fellowship training increases adenoma detection rates. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  Young Sun Kim,et al.  Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40–49 years undergoing screening colonoscopy , 2010, Journal of gastroenterology and hepatology.

[30]  Gheorghe Doros,et al.  The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. , 2007, Gastrointestinal endoscopy.

[31]  Youming Li,et al.  Epidemiological Trends in Colorectal Cancer in China: An Ecological Study , 2016, Digestive Diseases and Sciences.